Gene · 2000
NIH grants1,476
NIH grants whose papers are about the gene, through NIH's grant-paper links.
281 to 300 of 1,476
Download this page as JSON| Grant | Title | ELF4 papers | Newest fiscal year |
|---|---|---|---|
| R01CA201402 | The unique roles of the GTP-binding/protein crosslinking enzyme transglutaminase-2 and signaling partners in aggressive cancers | 1 | 2024 |
| R01CA229535 | Novel role of APOBEC3 enzymes as key mediators of cisplatin sensitivity through aberrant processing of interstrand crosslinks | 1 | 2024 |
| R01CA238237 | Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma | 1 | 2024 |
| R01CA242021 | Regulation of mitochondrial redox homeostasis and signaling in metastatic ovarian cancer | 1 | 2024 |
| R01DE029838 | Reconstructing early life environmental exposures using tooth biomarkers and their influence on the trajectory of the oral microbiome and oral health in childhood | 1 | 2024 |
| R01EY026545 | Cilium-associated structures in rod cells | 1 | 2024 |
| R01HD102186 | A system approach to the analysis of Heterotaxy Candidate Genes | 1 | 2024 |
| R01HG011207 | Computational methods to identify neo-TADs and enhancer-hijacking in rearranged genomes | 1 | 2024 |
| R01HL148153 | Type I Interferon Responses in the Pathobiology of Anthracycline-induced Cardiotoxicity | 1 | 2024 |
| R01HL151535 | Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway. | 1 | 2024 |
| R01HL151983 | Decoding temporal epithelial signaling programs to restore homeostasis in acute lung injury | 1 | 2024 |
| R01HL156846 | PDGFD regulates a transcriptional network to modulate smooth muscle cell transition and coronary artery disease risk | 1 | 2024 |
| R01HL157456 | CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction | 1 | 2024 |
| R01MD015409 | Understanding Mechanisms Underlying Chronic Stress-Induced Asthma in Children by Population and Single-Cell Epigenomics Approaches | 1 | 2024 |
| R01MH108826 | The Impact of Traumatic Stress on the Methylome: implications for PTSD | 1 | 2024 |
| R01NS114413 | Development of autophagy modulators for evaluation as a therapeutic strategy for Niemann-Pick Type C | 1 | 2024 |
| R35CA232113 | Targeting undruggable RAS for cancer treatment | 1 | 2024 |
| R35GM138342 | Statistical Methods for Bulk-Tissue and Single-Cell Multi-Omics Integration | 1 | 2024 |
| R35HG011279 | Joint analysis of 3D chromatin organization and 1D epigenome | 1 | 2024 |
| R35HG011324 | Mapping enhancer-gene regulation in single cells to connect genetic variants to target genes and cell types | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2000/grants?page=15